
ScienceMore in Science→
Genetic variants may blunt blood-sugar response to GLP-1 drugs
Key Takeaways
- Researchers linked certain variants to weaker glycemic response to GLP-1 drugs.
- The study estimates roughly 10% of people carry these variants.
- The finding may help move diabetes treatment toward precision medicine.
DE
DT Editorial Team··via sciencedaily.com